Hidenori Toyoda Selected Research

Hidenori Toyoda Research Topics

Disease

198	Hepatocellular Carcinoma (Hepatoma) 05/2024 - 03/2002
77	Infections 12/2023 - 11/2002
62	Chronic Hepatitis C 02/2024 - 03/2002
52	Neoplasms (Cancer) 01/2024 - 11/2005
50	Fibrosis (Cirrhosis) 05/2024 - 01/2006
27	Chronic Hepatitis B 04/2024 - 07/2006
25	Liver Cirrhosis (Hepatic Cirrhosis) 05/2024 - 02/2004
23	Liver Diseases (Liver Disease) 12/2023 - 04/2011
18	Liver Neoplasms (Liver Cancer) 05/2024 - 08/2005
15	Hepatitis B 04/2024 - 01/2007
14	Hepatitis C 10/2023 - 04/2008
13	Non-alcoholic Fatty Liver Disease 03/2024 - 02/2013
10	Inflammation (Inflammations) 04/2024 - 02/2004
9	Hemorrhage 04/2024 - 04/2008
9	Neoplasm Metastasis (Metastasis) 12/2023 - 05/2004
6	Fatty Liver 10/2023 - 02/2013
6	Hypertension (High Blood Pressure) 10/2023 - 01/2022
6	Hepatitis 01/2022 - 07/2006
6	Chronic Hepatitis (Chronic Active Hepatitis) 12/2020 - 04/2007
5	Chronic Renal Insufficiency 10/2023 - 01/2018
5	Fatigue 01/2023 - 01/2022
5	Virus Diseases (Viral Diseases) 01/2023 - 12/2009
5	Carcinogenesis 12/2020 - 03/2002
4	Alcoholic Fatty Liver 01/2023 - 01/2012
4	Disease Progression 01/2022 - 03/2015
4	Anemia 05/2019 - 02/2014
4	Hemophilia A (Haemophilia) 03/2012 - 06/2004
3	Thrombosis (Thrombus) 08/2023 - 02/2021
3	Diabetes Mellitus 10/2022 - 01/2020
3	Ascites 05/2022 - 12/2012
3	Viremia 01/2021 - 01/2007
3	Persistent Infection 12/2020 - 01/2014

Drug/Important Bio-Agent (IBA)

64	Antiviral Agents (Antivirals)IBA 05/2024 - 11/2007
43	lenvatinibIBA 04/2024 - 01/2019
40	atezolizumabIBA 05/2024 - 01/2022
40	Bevacizumab (Avastin)FDA Link 05/2024 - 01/2022
38	InterferonsIBA 01/2023 - 03/2002
37	AlbuminsIBA 05/2024 - 01/2016
32	BilirubinIBA 05/2024 - 03/2009
28	Ribavirin (Virazole)FDA LinkGeneric 10/2023 - 03/2005
23	Biomarkers (Surrogate Marker)IBA 03/2024 - 12/2006
20	alpha-Fetoproteins (alpha-Fetoprotein)IBA 11/2023 - 08/2005
15	Tumor Biomarkers (Tumor Markers)IBA 08/2023 - 01/2006
15	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2011
15	Hepatitis B Surface Antigens (HBsAg)FDA Link 12/2022 - 01/2007
14	Fetal Proteins (Fetoprotein)IBA 05/2024 - 09/2007
13	Alanine Transaminase (SGPT)IBA 04/2024 - 03/2002
13	lentil lectinIBA 03/2024 - 08/2005
12	RNA (Ribonucleic Acid)IBA 12/2020 - 03/2002
11	AntigensIBA 04/2024 - 01/2016
11	acarboxyprothrombin (PIVKA)IBA 03/2024 - 09/2007
10	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 06/2004
9	MicroRNAs (MicroRNA)IBA 12/2020 - 05/2010
8	entecavir FDA Link 03/2024 - 07/2018
8	Pentetic Acid (DTPA)FDA LinkGeneric 07/2022 - 07/2011
8	GadoliniumIBA 07/2022 - 07/2011
8	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2017 - 06/2007
7	Sorafenib (BAY 43-9006)FDA Link 01/2023 - 04/2013
7	SofosbuvirIBA 03/2022 - 11/2014
7	gadolinium ethoxybenzyl DTPA FDA Link 01/2021 - 07/2011
6	tenofovir alafenamideIBA 04/2024 - 01/2021
6	Serum AlbuminIBA 10/2023 - 03/2015
6	Indicators and Reagents (Reagents)IBA 01/2023 - 09/2015
6	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2022 - 01/2015
6	glecaprevir and pibrentasvirIBA 05/2020 - 01/2018
5	Tenofovir (Viread)FDA Link 03/2024 - 07/2018
5	NucleotidesIBA 10/2023 - 01/2008
5	Immune Checkpoint InhibitorsIBA 06/2023 - 06/2020
5	Branched-Chain Amino AcidsIBA 01/2020 - 03/2014
5	asunaprevirIBA 08/2019 - 07/2016
5	daclatasvirIBA 08/2019 - 07/2016
5	Ritonavir (Norvir)FDA Link 04/2019 - 10/2015
5	ombitasvirIBA 04/2019 - 10/2015
5	paritaprevirIBA 04/2019 - 10/2015
4	Protons (Proton)IBA 12/2023 - 01/2019
4	EnzymesIBA 12/2023 - 01/2008
4	C-Reactive ProteinIBA 01/2023 - 01/2022
4	Transaminases (Aminotransferases)IBA 02/2022 - 01/2015
4	Hepatitis B e AntigensIBA 01/2022 - 11/2018
4	Hyaluronic Acid (Hyaluronan)IBA 01/2021 - 12/2012
4	Tyrosine (L-Tyrosine)FDA Link 01/2020 - 09/2015
4	telaprevirIBA 04/2015 - 01/2014
3	NucleosidesIBA 04/2024 - 03/2012
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 01/2022
3	Protease Inhibitors (Protease Inhibitor)IBA 10/2023 - 01/2017
3	Small Heat-Shock ProteinsIBA 12/2022 - 01/2016
3	velpatasvirIBA 03/2022 - 07/2018
3	Keratin-18 (Keratin 18)IBA 11/2021 - 01/2017
3	ledipasvirIBA 03/2021 - 06/2015
3	pibrentasvirIBA 08/2020 - 01/2018
3	glecaprevirIBA 08/2020 - 01/2018
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2019

Therapy/Procedure

116	Therapeutics 05/2024 - 03/2002
6	Liver Transplantation 04/2023 - 01/2014
5	Aftercare (After-Treatment) 01/2022 - 12/2012
5	Renal Dialysis (Hemodialysis) 02/2019 - 07/2016
5	Hepatectomy 01/2016 - 08/2008
4	Duration of Therapy 08/2020 - 01/2009
4	Drug Therapy (Chemotherapy) 01/2020 - 05/2004
4	Radiofrequency Ablation 02/2018 - 12/2012